Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Midday movers: Tesla, Coinbase, and more

Published 12/27/2023, 07:30 AM
Updated 12/27/2023, 12:02 PM
© Reuters.

(Updated - December 27, 2023 12:00 PM EST)

Investing.com -- Main U.S. indexes were largely unchanged Wednesday, stabilizing after recent gains during the last trading week of what has been a positive year.

Here are some of the biggest U.S. stock movers today:

Tesla (NASDAQ:TSLA) stock rose 2.2% with Bloomberg reporting that the electric car maker is preparing to launch a revamped version of its Model Y from its Shanghai plant.

Intel (NASDAQ:INTC) stock rose 0.4% after Israel's government agreed to give the tech giant a $3.2 billion grant for a new $25 billion chip plant it plans to build in southern Israel, in what would be the largest investment ever by a company in Israel.

Apple (NASDAQ:AAPL) stock fell 0.5% after Bloomberg reported that executive Tang Tan, who led design for the iPhone and Apple Watch, is set to join LoveFrom, a new artificial intelligence hardware project.

Coherus BioSciences (CHRS) stock soared over 20% after the U.S. FDA approved a new delivery service for its post-chemotherapy treatment.

Toyota (NYSE:TM) ADRs rose 0.4% after data showed the world's largest auto maker's global production jumped 11% in November to a record level, bouncing back from last year's supply chain disruptions.

Coinbase (NASDAQ:COIN) stock rose 6.7% with the cryptocurrency exchange benefiting from the bounce in bitcoin, the most widely used digital currency. Marathon Digital (Nasdaq: NASDAQ:MARA) and MicroStrategy (Nasdaq: MSTR) also gained.

Bit Digital (BTBT) stock rose 15% as the U.S.-based bitcoin miner plans to double its mining operating fleet to about 6.0 ether per second in 2024.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cytokinetics (NASDAQ:CYTK) stock rose 70% after it reported positive results from its phase 3 study of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.

Iovance Biotherapeutics (NASDAQ:IOVA) stock fell 23% after announcing that the FDA placed a clinical hold on the IOV-LUN-202 trial in response to a recently reported Grade 5 (fatal) serious adverse event.


Additional reporting by Louis Juricic

Latest comments

Mitch just missed a major rally and a chance to Make a lot of money. several traders warned him but as usual his prejudice flooded his judgement. don't let this happen to you.
The problem we have is because Most people always taught that you only need a good job to become rich,These billionaires are operating on a whole other playbook that many don't even know exists✓✓✓✓✓✓✓✓✓✓✓✓✓[
And the curtain rises on the predictable "late trade" magic show.  Fraudulent, criminally manipulated JOKE.
I'm up $1.95 million in 2023.   "What's in your wallet?"
and the curtain rises on more of mitch's bs
/Mitch just missed a major chance to make a lot of money he was warned. too bad.
The biggest investment JOKE in the world continues to financially defile America in broad daylight.
Banks Terminate 60,000 Workers in 2023. Just in case you missed it. I'm sure its nothing
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.